*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.
Boston Scientific's upcoming earnings report on October 22 is poised to capture attention, particularly given the company's impressive market cap of over $141 billion, which underscores its significant presence in the medical device industry. Analysts are anticipating an EPS of $0.71, yet the whisper number suggests a more optimistic outlook at $0.81, hinting at potential upside surprises. With revenue expected to reach $4.97 billion, investors will be keenly observing how Boston Scientific navigates its growth trajectory amidst a competitive landscape. The absence of recent news leaves room for speculation, but the company's historical resilience and strategic focus on innovation could play pivotal roles in meeting or exceeding these expectations. As the market awaits, the whisper number serves as a subtle indicator of the confidence surrounding Boston Scientific's ability to deliver robust financial performance.
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Website: https://www.bostonscientific.com
Average Sentiment Score:
Overall Sentiment: